The PPARα agonist fenofibrate reduces the cytokine imbalance in a maternal immune activation model of schizophrenia.

[1]  M. A. De Luca,et al.  Correction to: Adolescent self‑administration of the synthetic cannabinoid receptor agonist JWH‑018 induces neurobiological and behavioral alterations in adult male mice , 2023, Psychopharmacology.

[2]  A. Manduca,et al.  Maternal Immune Activation Induced by Prenatal Lipopolysaccharide Exposure Leads to Long-Lasting Autistic-like Social, Cognitive and Immune Alterations in Male Wistar Rats , 2023, International journal of molecular sciences.

[3]  M. Pistis,et al.  Maternal immune activation impairs endocannabinoid signaling in the mesolimbic system of adolescent male offspring , 2023, Brain, Behavior, and Immunity.

[4]  Zhanjun Jia,et al.  Anti-inflammatory role of fenofibrate in treating diseases , 2023, Biomolecules and biomedicine.

[5]  R. Perlis,et al.  Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During Pregnancy , 2022, JAMA network open.

[6]  M. Pistis,et al.  Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation , 2022, Frontiers in Pharmacology.

[7]  R. Perlis,et al.  COVID-19 in pregnancy: implications for fetal brain development , 2022, Trends in Molecular Medicine.

[8]  M. Pistis,et al.  Repurposing Peroxisome Proliferator-Activated Receptor Agonists in Neurological and Psychiatric Disorders , 2021, Pharmaceuticals.

[9]  R. Dale,et al.  Maternal immune activation and neuroinflammation in human neurodevelopmental disorders , 2021, Nature Reviews Neurology.

[10]  R. Vitale,et al.  The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation , 2021, Cells.

[11]  M. Pistis,et al.  Endocannabinoid-Like Lipid Neuromodulators in the Regulation of Dopamine Signaling: Relevance for Drug Addiction , 2020, Frontiers in Synaptic Neuroscience.

[12]  José M S Fernández-Calleja,et al.  The poly(I:C)-induced maternal immune activation model; a systematic review and meta-analysis of cytokine levels in the offspring , 2020, Brain, behavior, & immunity - health.

[13]  D. Beversdorf,et al.  Maternal Immune Activation Induces Neuroinflammation and Cortical Synaptic Deficits in the Adolescent Rat Offspring , 2020, International journal of molecular sciences.

[14]  F. Pavón,et al.  Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases , 2020, Frontiers in Pharmacology.

[15]  P. Garcia-Valtanen,et al.  Maternal host responses to poly(I:C) during pregnancy leads to both dysfunctional immune profiles and altered behaviour in the offspring , 2020, American journal of reproductive immunology.

[16]  Tyrone D. Cannon,et al.  Cytokine concentrations throughout pregnancy and risk for psychosis in adult offspring: a longitudinal case-control study. , 2020, The lancet. Psychiatry.

[17]  L. Cui,et al.  Cortical Neuron-Derived Exosomal MicroRNA-181c-3p Inhibits Neuroinflammation by Downregulating CXCL1 in Astrocytes of a Rat Model with Ischemic Brain Injury , 2019, Neuroimmunomodulation.

[18]  Karen L. Jones,et al.  An Exploratory Examination of Neonatal Cytokines and Chemokines as Predictors of Autism Risk: The Early Markers for Autism Study , 2019, Biological Psychiatry.

[19]  C. Matar,et al.  Probiotic consumption during puberty mitigates LPS-induced immune responses and protects against stress-induced depression- and anxiety-like behaviors in adulthood in a sex-specific manner , 2019, Brain, Behavior, and Immunity.

[20]  M. Piquette-Miller,et al.  Poly(I:C) alters placental and fetal brain amino acid transport in a rat model of maternal immune activation , 2019, American journal of reproductive immunology.

[21]  L. Lv,et al.  Age-related changes in neuroinflammation and prepulse inhibition in offspring of rats treated with Poly I:C in early gestation , 2019, Behavioral and Brain Functions.

[22]  B. Morris,et al.  JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk , 2019, Journal of Neuroinflammation.

[23]  M. Pistis,et al.  The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia , 2018, CNS neuroscience & therapeutics.

[24]  U. Meyer,et al.  Mouse models of maternal immune activation: Mind your caging system! , 2018, Brain, Behavior, and Immunity.

[25]  R. Yolken,et al.  Maternal immune activation: reporting guidelines to improve the rigor, reproducibility, and transparency of the model , 2018, Neuropsychopharmacology.

[26]  Edmond J. Breen,et al.  Cytokine levels and associations with symptom severity in male and female children with autism spectrum disorder , 2017, Molecular Autism.

[27]  W. Liu,et al.  Fenofibrate attenuates fatty acid-induced islet β-cell dysfunction and apoptosis via inhibiting the NF-κB/MIF dependent inflammatory pathway. , 2017, Metabolism: clinical and experimental.

[28]  J. Pakan,et al.  Acute in utero exposure to lipopolysaccharide induces inflammation in the pre- and postnatal brain and alters the glial cytoarchitecture in the developing amygdala , 2017, Journal of Neuroinflammation.

[29]  P. Ashwood,et al.  Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation , 2017, Brain, Behavior, and Immunity.

[30]  H. Oliveira,et al.  Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death , 2017, Oxidative medicine and cellular longevity.

[31]  Burkhard Becher,et al.  GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation. , 2016, Immunity.

[32]  M. Pistis,et al.  PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors , 2016, Neuropharmacology.

[33]  Jingping Zhao,et al.  Altered plasma levels of chemokines in autism and their association with social behaviors , 2016, Psychiatry Research.

[34]  A. McAllister,et al.  Maternal immune activation: Implications for neuropsychiatric disorders , 2016, Science.

[35]  V. Zídek,et al.  Hepatotoxic effects of fenofibrate in spontaneously hypertensive rats expressing human C-reactive protein. , 2016, Physiological research.

[36]  F. Dai,et al.  Fenofibrate improves high-fat diet-induced and palmitate-induced endoplasmic reticulum stress and inflammation in skeletal muscle. , 2016, Life sciences.

[37]  M. Pistis,et al.  Maternal Immune Activation Disrupts Dopamine System in the Offspring , 2016, The international journal of neuropsychopharmacology.

[38]  B. Aisbett,et al.  Relationships between inflammatory cytokine and cortisol responses in firefighters exposed to simulated wildfire suppression work and sleep restriction , 2015, Physiological reports.

[39]  E. Kong,et al.  The poly(I:C)-induced maternal immune activation model in preclinical neuropsychiatric drug discovery. , 2015, Pharmacology & therapeutics.

[40]  F. Gonzalez,et al.  GC-MS metabolomics on PPARα-dependent exacerbation of colitis. , 2015, Molecular bioSystems.

[41]  J. Howland,et al.  Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: Implications for neurodevelopmental psychiatric disorders , 2015, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[42]  Jian-feng Wei,et al.  Expression of CCL2 and CCR2 in the hippocampus and the interventional roles of propofol in rat cerebral ischemia/reperfusion , 2014, Experimental and therapeutic medicine.

[43]  B. Baune,et al.  Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies , 2014, Neuroscience & Biobehavioral Reviews.

[44]  U. Meyer.  Prenatal Poly(I:C) Exposure and Other Developmental Immune Activation Models in Rodent Systems , 2014, Biological Psychiatry.

[45]  D. Sarkar,et al.  Crosstalk between the circadian clock circuitry and the immune system , 2013, Chronobiology international.

[46]  M. Reilly,et al.  Peroxisome Proliferator–Activated Receptor-α Agonism With Fenofibrate Does Not Suppress Inflammatory Responses to Evoked Endotoxemia , 2012, Journal of the American Heart Association.

[47]  J. Brusés.  Maternal immune activation by poly(I:C) induces expression of cytokines IL-1β and IL-13, chemokine MCP-1 and colony stimulating factor VEGF in fetal mouse brain , 2012, Journal of Neuroinflammation.

[48]  P. Kamerman,et al.  Fever and inflammatory cytokine response in rats injected subcutaneously with viral double-stranded RNA analog, polyinosinic:polycytidylic acid (Poly-I:C) , 2011 .

[49]  P. Carpentier,et al.  Placental TNF-α signaling in illness-induced complications of pregnancy. , 2011, The American journal of pathology.

[50]  Y. Yoshihara,et al.  Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders , 2011, PloS one.

[51]  Y. Hattori,et al.  Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate-activated protein kinase activation. , 2011, Metabolism: clinical and experimental.

[52]  I. Hertz-Picciotto,et al.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders , 2011, Journal of Neuroimmunology.

[53]  A. Patruno,et al.  Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls , 2011, BMC Neuroscience.

[54]  P. Patterson.  Immune involvement in schizophrenia and autism: Etiology, pathology and animal models , 2009, Behavioural Brain Research.

[55]  Benjamin E. Deverman,et al.  Cytokines and CNS Development , 2009, Neuron.

[56]  R. Romero,et al.  Activation of TLR3 in the trophoblast is associated with preterm delivery. , 2009, American journal of reproductive immunology.

[57]  J. Hamilton.  Colony-stimulating factors in inflammation and autoimmunity , 2008, Nature Reviews Immunology.

[58]  B. Staels,et al.  Systemic and distal repercussions of liver-specific peroxisome proliferator-activated receptor-alpha control of the acute-phase response. , 2008, Endocrinology.

[59]  Urs Meyer,et al.  The Time of Prenatal Immune Challenge Determines the Specificity of Inflammation-Mediated Brain and Behavioral Pathology , 2006, The Journal of Neuroscience.

[60]  R. Ransohoff,et al.  The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.

[61]  E. Stanley,et al.  Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.

[62]  J. Gilmore,et al.  Maternal poly I:C exposure during pregnancy regulates TNFα, BDNF, and NGF expression in neonatal brain and the maternal–fetal unit of the rat , 2005, Journal of Neuroimmunology.

[63]  K. Krause,et al.  Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases , 2005, Brain Research Reviews.

[64]  I. Weiner,et al.  Immune Activation During Pregnancy in Rats Leads to a PostPubertal Emergence of Disrupted Latent Inhibition, Dopaminergic Hyperfunction, and Altered Limbic Morphology in the Offspring: A Novel Neurodevelopmental Model of Schizophrenia , 2003, Neuropsychopharmacology.

[65]  B. Williams,et al.  Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.

[66]  J. Lieberman,et al.  Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain , 2001, Schizophrenia Research.

[67]  S. Poole,et al.  The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia , 2006, Molecular Psychiatry.

[68]  L C Harrison,et al.  The chronobiology of human cytokine production. , 1998, International reviews of immunology.